Aromatase inhibitors for the treatment of infertility

Bibliography

• EVANS D, EVANS M: Fertility, infertility and human embryo: ethics, law and practice of human artificial procreation. Hum. Reprod. Update (1996) 2:208–224.
   PubMed Web of Science ®Google Scholar
• HARGREAVE TB, ELTON RA: Fecundability rates from an infertile male population. Br. J. Um]. (1986) 58:194–196.
   Web of Science ®Google Scholar
• FARLEY TMM, BELSEY FH: The prevalence and etiology of infertility. In: Biological Components of Fertility (Vol. 1). Proceedings of the African Population Conference, Dakar, Senegal, International Union for the Scientific Study of Population, Liege, Belgium (1988):2.1.15–2.1.30.
   Google Scholar
• TEMPLETON A: Infertility-epidemiology, aetiology and effective management. Health Bull. (1995) 53(5):294–298.
   Google Scholar
• HULL M, GLAZENER C, KELLY NJ, CONWAY DI, FOSTER PA, HINTON RA et al.: Population study of causes, treatment, and outcome of infertility. Br. Med. J. (1985) 291:693–1697.
   PubMedGoogle Scholar
• TEMPLETON A, FRASER C, THOMPSON B: The epidemiology of infertility in Aberdeen. BE Med. J. (1990) 301:148–152.
   PubMed Web of Science ®Google Scholar
• SNICK HKA, SNICK TS, EVERS JLH,COLLINS JA: The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum. Reprod. (1997) 12:1582.
   PubMed Web of Science ®Google Scholar
• CAHILL DJ, WARDLE PG: Management of infertility. Br. Med. J. (2002) 325(6):28–32.
   PubMedGoogle Scholar
• SHOHAM Z, WEISSMAN A: Polycystic ovarian disease: obesity and insulin resistance. Proc. hit. Fed. Fertility Soc. (1998):263–272.
   Google Scholar
• FRANKS S: Polycystic ovary syndrome. N Engl. J. Med. (1995) 333:853–861.
   PubMed Web of Science ®Google Scholar
• GUZICK DS, CARSON SA, COUTIFARIS C et al: Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl. J. Med. (1999) 340:177–183.
   PubMed Web of Science ®Google Scholar
• MELTS GB, PAOLETTI AM, STRIGINI Fet al: Pharmacologic induction of multiple follicular development improves the success rate of artificial insemination with husband's semen in couples with male-related or unexplained infertility. Fertil. Steril (1987) 47:441–445.
   PubMed Web of Science ®Google Scholar
• DODSON WC, WHITESIDES DB, HUGHES CL et al.: Superovulation with intrauterine insemination in the treatment of infertility: a possible alternative to gamete intrafallopian transfer and in vitro fertilization. Feral. Stern. (1987) 48:441–445.
   PubMed Web of Science ®Google Scholar
• SERHAL PF, KATZ M, LITTLE V, WORONOWSKI H: Unexplained infertility: the value of Pergonal superovulation combined with intrauterine insemination. Fertil. Steil]. (1988) 49:602–606.
   PubMed Web of Science ®Google Scholar
• FIORETTI P, PAOLETTI AM, STRIGINI F et al.: Induction of multiple follicular development as a therapy for unexplained or male-related infertility. Cynecol. Endocrinol. (1989) 3:45–53.
   PubMed Web of Science ®Google Scholar
• MELTS GB, STRIGINI F, MATS V et al:Critical reappraisal of the clinical effectiveness of different methods of assisted fertilization. Endocrinol Invest. (1990) 13:263–274.
   PubMed Web of Science ®Google Scholar
• KEMMANN E, BOHRER M, SHELDEN R et al.: Active ovulation management increases the monthly probability of pregnancy occurrence in ovulatory women who receive intrauterine insemination. Feral. Stern. (1987) 48:916–920.
   PubMed Web of Science ®Google Scholar
• MELDRUM DR, WISOT A, HAMILTON F et al.: Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fe/tn. Stern. (1989) 51:455–459.
   PubMed Web of Science ®Google Scholar
• LAUFER N, DECHERNEY AH, HASELTINE FP et al.: The use of high-dose human menopausal gonadotropin in an in vitro fertilization program. Fertil. Steril (1983) 40:734–741.
   PubMed Web of Science ®Google Scholar
• BERGH PA, NAVOT D: Ovarian hyperstimulation syndrome: a review of pathophysiology. I Assist. Reprod. Genet. (1992) 9:429–438.
   PubMed Web of Science ®Google Scholar
• GOMPEL A, MAUVAIS-JARVIS P: Induction of ovulation with pulsatile GnRH in hypothalamic amenorrhoea. Hum. Reprod. (1988) 3:473–477.
   PubMed Web of Science ®Google Scholar
• LIN SG, GU CX, XU L et al: Experience with bromocriptine for the treatment of female infertility due to hyperprolactinemia.ChM Med. J. (Engl.) (1991) 104:679–684.
   PubMed Web of Science ®Google Scholar
• THE ESHRE CAPRI WORKSHOP: Female infertility: treatment options for complicated cases. Hum. Reprod. (1997) 12:1191–1196.
   PubMed Web of Science ®Google Scholar
• THE ESHRE CAPRI WORKSHOP: Infertility revisited: the state of the art today and tomorrow Hum. Reprod. (1996) 11:1779–1807.
   Web of Science ®Google Scholar
• DUNAIF A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev (1997) 18:774–800.
   PubMed Web of Science ®Google Scholar
• DUNAIF A, SEGAL KR, FUTTERWEIT W, DOBRJANSKY A: Profound peripheral insulin resistance, indepentent of obesity, in polycystic ovary syndrome. Diabetes (1989) 38:1165–1174.
   PubMed Web of Science ®Google Scholar
• FRANKS S: Polycystic ovary syndrome: a changing perspective. Chit. Endocrinol. (1989) 31:87–120.
   PubMed Web of Science ®Google Scholar
• DUNAIF A: Molecular mechanisms of insulin resistance in the polycystic ovary syndrome. Semin. Reprod. Endrocrinol. (1994) 12:15–20.
   Google Scholar
• NESTLER JE, STOVALL D, AKHTER N, IUORNO MJ, JAKUBOWICZ MJ: Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fe/tn. Sterll. (2002) 77:209–215.
   PubMed Web of Science ®Google Scholar
• DUNAIF A, SCOTT D, FINEGOOD D et al.: The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in polycystic ovary syndrome. J. Chit. Endocrinol. Metab. (1996) 81:3299–3306.
   PubMed Web of Science ®Google Scholar
• EHRMANN DA, SCHNEIDER DJ, SOBEL BE et al.: Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. (1997) 82:2108–2116.
   PubMed Web of Science ®Google Scholar
• HASEGAWA I, MURAKAWA H, SUZUKI M, YAMAMOTO Y, KURABAYASHI T, TANAKA K: Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Fertil. Steil]. (1999) 71:323–327.
   PubMed Web of Science ®Google Scholar
• MITWALLY MFM, KUSCU NK, YALCINKAYA TM: High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome. Hum. Reprod. (1999) 14:2700–2703.
   PubMed Web of Science ®Google Scholar
• AZZIZ R, EHRMANN D, LEGRO RS et al.: Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind placebo-controlled trial. I. Clia Endocrinol. Metab. (2001) 86:1626–1632.
   PubMed Web of Science ®Google Scholar
• THYER AC, BRZYSKI R, EASTON C, SCHENKEN R: A comparison of the effect of metformin and rosiglitazone on insulin action and secretion in women with polycystic ovary syndrome. Feral. Steil]. (2002) 78:S105–S106.
   Web of Science ®Google Scholar
• GHAZEERI GC, HAAS D, KE RW, BARKER LJ, KUTTEH WH: The use of rosiglitazone in ovulation induction in clomiphene-resistant obese women with polycystic ovary syndrome. Feral. Steil]. (2001) 76(3, Suppl. 1):536–537.
   Google Scholar
• MITWALLY MFM, GREENBLATT EM, CASPER RF: Rosiglitazone improves endocrine and reproductive performance in women with polycystic ovary syndrome (PCOS) who failed to respond to metformin. Fertil. Steril (2001) 76(3, Suppl. 1):S206.
   Google Scholar
• CATALDO NA, ABBASI F, MCLAUGHLIN TL, FECHNER PY, REAVEN GM, GIUDICE LC: Rosiglitazone in insulin-resistant women with polycystic ovary syndrome (PCOS): effects on ovarian function and metabolism. Feral. Steil]. (2002) 78:S36.
   Web of Science ®Google Scholar
• COSTELLO ME EDEN JA: A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil. Steil]. (2003) 79(1):1–13.
   PubMed Web of Science ®Google Scholar
• BLANK RH: Assisted reproduction and reproductive rights: the case of in vitro fertilization. Politics Life Sri. (1997) 16(2):279–288.
   PubMed Web of Science ®Google Scholar
• LEUNG CK: Recent advances in clinical aspects of in vitro fertilisation. Hong Kong Med. J. (2000) 6(2):169–176.
   PubMedGoogle Scholar
• EDWARDS RG, BAVISTER BD, STEPTOE PC: Early stages of fertilization in vitroof human oocytes matured in vitro. Nature (1969) 221:632–635.
   PubMed Web of Science ®Google Scholar
• STEPTOE PC, EDWARDS RG: Birth after the reimplantation of a human embryo. Lancet (1978) 2:366.
   PubMed Web of Science ®Google Scholar
• MOHR LR, TROUNSON AO: Cryopreservation of human embryos. Ann. NY Acad. Sri. (1985) 442:536–543.
   PubMed Web of Science ®Google Scholar
• PALERMO G, JORIS H, DEVROEY P, VAN STEIRTEGHEM AC: Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet (1992) 340:17–18.
   PubMed Web of Science ®Google Scholar
• HANDYSIDE AH, KONTOGIANNI EH, HARDY K, WINSTON RM: Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature (1990) 344:768–770.
   PubMed Web of Science ®Google Scholar
• HARDY K: Development of human blastocysts in vitro. In: Preimplantation Embryo Development. BD Bavister (Ed.), Springer-Verlag, New York (1993):184–199.
   Google Scholar
• HARDY K, SPANOS S, BECKER D, IANNELLI P, WINSTON RM, STARK J: From cell death to embryo arrest: mathematical models of human preimplantation embryo development. Proc. Nat. Acad. Li. USA (2001) A98:1655-1660.
   Google Scholar
• GARDNER DK, LANE M, SCHOOLCRAFT WB: Culture systems and blastocyst development. In: Serono Symposia USA, International Symposium on ART and Human Blastocyst (2000):14.
   Google Scholar
• HARDY K, WRIGHT C, RICE S et al: Future developments in assisted reproduction in humans. Reproduction (2002) 123(2):171–183.
   PubMed Web of Science ®Google Scholar
• COLE PA, ROBINSON CH: Mechanism and inhibition of cytochrome P450 aromatase. I Med. Chem. (1990) 33:2933–2944.
   PubMed Web of Science ®Google Scholar
• AKHTAR M, NJAR VCO, WRIGHT JN: Mechanistic studies on aromatase and related C-C bond cleaving P450 enzymes. Steroid Biochem. Mol. Biol. (1993) 44:375–387.
   PubMed Web of Science ®Google Scholar
• SANTEN RJ, MANNI A, HARVEY H, REDMOND C: Endocrine treatment of breast cancer in women. Endocrine Rev (1990) 11:1–45.
   Google Scholar
• LONNING PE: Aromatase inhibition for breast cancer treatment. Acta Oncolog. (1996) 35\(Suppl. 5):38–43.
   Google Scholar
• BUZDAR A, HOWELL A: Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. Clin. Cancer. Res. (2001) 7:2620–2635
   PubMed Web of Science ®Google Scholar
• GOSS PE, STRASSER K: Aromatase inhibitors. I Clin. Oncol (2001)19:881–894.
   PubMed Web of Science ®Google Scholar
• BRUEGGEMEIER RW: Aromatase inhibitors: mechanisms of steroidal inhibitors. Br. Cancer Res. Treat. (1994) 30:31–42.
   PubMed Web of Science ®Google Scholar
• BOSSCHE HV, MOEREELS H, KOYMANS LMH: Aromatase inhibitors: Mechanisms for non-steroidal inhibitors. Br. Cancer Res. Treat. (1994) 30:43–55.
   PubMed Web of Science ®Google Scholar
• COOMBES RC, GOSS P, DOWSETT M, GAZET JC, BRODIE AMH: 4-Hydroxyandrostenedione treatment of postmenopausal patients with advanced breast cancer. Lancet (1984) 2:1237–1239.
   PubMed Web of Science ®Google Scholar
• BRODIE AM, NJAR VC: Aromatase inhibitors and breast cancer. Semi]. OncoL (1996) 23:10–20.
   PubMed Web of Science ®Google Scholar
• SANTEN RJ, LIPTON A, KENDALL J: Successful medical adrenalectomy with aminoglutethimide: role of altered drug metabolism../. Am. Med. Assoc. (1974) 230:1661.
   Google Scholar
• LIPTON A, SANTEN RJ: Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer. Cancer (1974) 33:503–512.
   PubMed Web of Science ®Google Scholar
• NEWSOME HH, BROWN PN, TERZ JJ et al: Medical and surgical adrenalectomy in patients with advanced breast carcinoma. Cancer (1977) 39:542–546.
   PubMed Web of Science ®Google Scholar
• WINER EP, HUDIS C, BURSTEIN HJ et al: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J. Clin. Oncol (2002) 20(15):3317–3327.
   PubMed Web of Science ®Google Scholar
• BUZDAR A, JONAT W, HOWELL A et al: Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two Phase III trials. J. Clin. Oncol (1996) 14:2000–2011.
   PubMed Web of Science ®Google Scholar
• MARTY M, GERSHANOVICH M, CAMPOS B et al.: AIs, anew potent, selective aromatase inhibitor superior to aminoglutethimide (AG) in postmenopausal women with advanced breast cancer previously treated with antioestrogens. Proc. Am. Soc. Clin. Oncol (1997) 16:156.
   Google Scholar
• BERGH J, BONNETERRE J, HOUSTON SJ et al: Vorozole (Rivizor) versus aminoglutethimide (AG) in the treatment of postmenopausal breast cancer relapsing after tamoxifen. Proc. Am. Soc. Oncol (1997) 16:156 (Abstract).
   Google Scholar
• DOWSETT M: Biological background to aromatase inhibition. Breast (1996) 5:196–201.
   Web of Science ®Google Scholar
• DRANITSARIS G, LEUNG P, MATHER J, OZA A: Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate. Anticancer Drugs (2000) 11(7):591–560.
   PubMed Web of Science ®Google Scholar
• SIOUFI A, GAUDUCHEAU N, PINEAU V et al.: Absolute bioavailability of letrozole in healthy post-menopausal women. Biopharm. Drug Dispos. (1997) 18:779–789.
   PubMed Web of Science ®Google Scholar
• SIOUFI A, SANDRENAN N, GODBILLON J et al.: Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration. Biopharm. Drug Dispos. (1997) 18(6):489–497.
   Google Scholar
• MCNEILLY AS: The control of FSH secretion. Acta Endocrinol (1988) 288:31–40.
   Google Scholar
• KAMAT A, HINSHELWOOD MM, MURRY BA, MENDELSON CR: Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab. (2002) 13(3):122–128.
   PubMed Web of Science ®Google Scholar
• NAFTOLIN F, MACLUSKY NJ: Aromatization hypothesis revisited. In: Differentiation: Basic and Clinical Aspects M Serio (Ed.), Raven Press, New York (1984):79–91.
   Google Scholar
• NAFTOLIN F, MACLUSKY NJ, LERANTH CZ, SAKAMOTO HS, GARCIA-SEGURA LM: The cellular effects of estrogens on neuroendocrine tissues. j Steroid Biochem. (1988) 30:195–207.
   PubMedGoogle Scholar
• NAFTOLIN F: Brain aromatization of androgens. I Reprod. Med. (1994) 39:257–261.
   PubMed Web of Science ®Google Scholar
• ROBERTS VJ, BARTH S, EL-ROEIY A,YEN SSC: Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. I Clin. Endocrinol Metab. (1994) 79:1434–1439.
   PubMed Web of Science ®Google Scholar
• YAMOTO M, MINAMI S, NAKANO R: Immunohistochemical localization of inhibin subunits in polycystic ovary. I Clin. Endocrinol Metab. (1993) 77:859–862.
   PubMed Web of Science ®Google Scholar
• JAATINEN T, PENTTILA T, KAIPIA A, EKFORS T, PARVINEN M, TOPPARI J: Expression of inhibin, PA and (3B messenger ribonucleic acids in the normal human ovary and in polycystic ovarian syndrome. Endocrinol (1994) 143:127–137.
   Web of Science ®Google Scholar
• ANDERSON RA, GROOME NP, BAIRD DT: Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin. Endocrinol (Oxf) (1998) 48:577–584.
   PubMed Web of Science ®Google Scholar
• LOCKWOOD GM, MUTTUKRISHNA S, GROOME NP, MATTHEWS DR, LEDGER WL: Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J. Clin. Endocrinol Metab. (1998) 83:1730–1735.
   PubMed Web of Science ®Google Scholar
• WEIL SJ, VENDOLA K, ZHOU J et al: Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. ./. Endocrinol Metab. (1998) 83(7):2479–2485.
   PubMed Web of Science ®Google Scholar
• WEIL S, VENDOLA K, ZHOU J, BONDY CA: Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J. Endocrinol Metab. (1999) 84(8):2951–2956.
   PubMed Web of Science ®Google Scholar
• VENDOLA KA, ZHOU J, ADESANYA 00, WEIL SJ, BONDY CA: Androgens stimulate early stages of follicular growth in the primate ovary. Clin. Invest. (1998) 101(12):2622–2629.
   Google Scholar
• VENDOLA K, ZHOU J, WANG J, FAMUYIWA OA, BIEVRE M, BONDY CA: Androgens promote oocyte insulin-like growth Factor I expression and initiation of follicle development in the primate ovary. Biol. Reprod. (1999) 61(2):353–357.
   PubMed Web of Science ®Google Scholar
• ADASHI E: Intraovarian regulation: the proposed role of insulin-like growth factors. Ann. NY Acad. Sri. (1993) 687:10–12.
   PubMed Web of Science ®Google Scholar
• GIUDICE LC: Insulin-like growth factors and ovarian follicular development. Endocr. Rev (1992) 13:641–669.
   PubMed Web of Science ®Google Scholar
• YEN SSC, LAUGHLIN GA, MORALES AJ: Interface between extra-and intra-ovarian factors in polycystic ovary syndrome (PCOS). Ann. NY Acad. Science (1993) 687:98–111.
   PubMed Web of Science ®Google Scholar
• AGARWAL SK, JUDD HL, MAGOFFIN DA: A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J. Clin. Endocrinol Metab. (1996) 81(10):3686–3691.
   PubMed Web of Science ®Google Scholar
• JAKIMIUK AJ, WEITSMAN SR, BRZECHFFA PR, MAGOFFIN DA: Aromatase mRNA expression in individual follicles from polycystic ovaries. MM. Hum. Reprod. (1998) 4(1):1–8.
   PubMed Web of Science ®Google Scholar
• MITWALLY MFM, CASPER RF: The use of an aromatase inhibitor for induction of ovulation in cases of clomiphene citrate failure. Program Abstr. Ann. Meet. Eur. Soc. Hum. Reprod. Embryo]. (2000) 15:71 (Abstract).
   Google Scholar
• MITWALLY MFM, CASPER RF: Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod. Technol (2000) 10:244–247.
   Google Scholar
• ••In this series of patients the authorsreported the success of an aromatase inhibitor in inducing ovulation in anovulatory women with PCOS. This was the first report in the literature showing the success of aromatase inhibition in clinical ovarian stimulation.
   Google Scholar
• MITWALLY MFM, CASPER RF: The aromatase inhibitor, letrozole: a promising alternative for clomiphene citrate for induction of ovulation. Feral. Steil]. (2000) 74(3, Suppl. 1):535 (Abstract).
   Google Scholar
• MITWALLY MFM, CASPER RF: Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Feral Stern. (2001) 75:305–309.
   PubMed Web of Science ®Google Scholar
• ••After showing the success of aromataseinhibition for ovarian stimulation, in this series of patients the authors report the success of an aromatase inhibitor in inducing ovulation in anovulatory women with PCOS and augmenting ovulation in ovulatory women with unexplained infertility. These women failed to respond to CC prior to using the aromatase inhibitor. Failure to respond to CC was defmed as failure to ovulate or ovulating without pregnancy because of a thin endometrium.
   Google Scholar
• FRANKS S, ADAMS J, MASON H, POLSON D: Ovulatory disorders in women with polycystic ovary syndrome. Clin. Obstet. Cynaecol. (1985) 12:605–632.
   Google Scholar
• HULL MGR: The causes of infertility and relative effectiveness of treatment. In: Infertility AA Templeton, JO Drife (Eds), Springer-Verlag, London (1992):33–62.
   Google Scholar
• KISTNER R: Induction of ovulation with clomiphene citrate (clomid). Obstet. Cynecol. Surv. (1965) 20:873–900.
   Google Scholar
• WYSOWSKI DE: Use of fertility drugs in the United States, 1979 through 1991. Feral. Steril (1993) 60:1096–1098.
   PubMed Web of Science ®Google Scholar
• GARCIA J, JONES GS, WENTZ AC: The use of clomiphene citrate. Feral. Steil]. (1977) 28:707–717.
   PubMed Web of Science ®Google Scholar
• GOLDFARB AF, MORALES A, RAKOFF AE, PROTOS P: Critical review of 160 clomiphene-related pregnancies. Obstet. Cynecol (1968) 31:342–345.
   Web of Science ®Google Scholar
• RANDALL JM, TEMPLETON A: Cervical mucus score and IP vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Feral. Steil]. (1991) 56:465–468.
   PubMed Web of Science ®Google Scholar
• GYSLER M, MARCH C, MISHELL DJ Jr, BAILEY EJ: A decade's experience with an individualized clomiphene treatment regimen including its effects on the postcoital test. Feral. Steril (1982) 37:161–167.
   PubMed Web of Science ®Google Scholar
• GELETY TJ, BUYALOS RP: The effect of clomiphene citrate and menopausal gonadotropins on cervical mucus in ovulatory cycles. Feral. Steril (1993) 60:471–476.
   PubMed Web of Science ®Google Scholar
• GONEN Y, CASPER RF: Sonographic determination of an adverse effect of clomiphene citrate on endometrial growth. Hum. Reprod. (1990) 5:670–674.
   PubMed Web of Science ®Google Scholar
• NELSON LM, HERSHLAG A, KURL RS, HALL JL, STILLMAN RJ: Clomiphene citrate directly impairs endometrial receptivity in the mouse. Feral Stern. (1990) 53:727–731.
   PubMed Web of Science ®Google Scholar
• LI TC, WARREN MA, MURPHY C, SARGEANT S, COOKE ID: A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal fertile women. BE J. Obstet. Cynaecol. (1992) 99:1008–1013.
   PubMedGoogle Scholar
• MIKKELSON TJ, KROBOTH PD, CAMERON WJ, DITTERT LW, CHUNGI V, MANBERG PJ: Single-dose pharmacokinetics of clomiphene citrate in normal volunteers. Feral. Steil]. (1986) 46:392–396.
   PubMed Web of Science ®Google Scholar
• HSU CC, KUO HC, WANG ST, HUANG KE: Interference with uterine blood flow by clomiphene citrate in women with unexplained infertility. Obstet. Cynecol. (1995) 86(6):917–921.
   Web of Science ®Google Scholar
• OKTAY K, BERKOWITZ P, BERKUS M, SCHENKEN RS, BRZYSKI RG: The re-incarnation of an old question clomid effect on oocyte and embryo? Feral. Steril (2000) 74(2):422.
   PubMed Web of Science ®Google Scholar
• BRANIGAN EF, ESTES MA: Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Fertil. Steril (2000) 73(3):587–590.
   PubMed Web of Science ®Google Scholar
• ZAYED F: Outcome of stimulated in vitro fertilisation (SIVF) using clomiphene citrate and human menopausal gonadotropin in different infertility groups. Clin. Exp. Obstet. Cynecol (1999) 26(3-4):227–279.
   PubMedGoogle Scholar
• SCHMIDT GE, KIM MH, MANSOUR R, TORELLO L, FRIEDMAN CI: The effects of enclomiphene and zuclomiphene citrates on mouse embryos fertilized in vitro and in vivo. Am. I Obstet. Cynecol (1986) 154(4):727–736.
   PubMed Web of Science ®Google Scholar
• YOSHIMURA Y, HOSOI Y, ATLAS SJ, WALLACH EE: Effect of clomiphene citrate on in vitro ovulated ova. Fertil. Steril. (1986) 45(6):800–804.
   PubMed Web of Science ®Google Scholar
• LONDON SN, YOUNG D, CALDITO G, MAILHES JB: Clomiphene citrate-induced perturbations during meiotic maturation and cytogenetic abnormalities in mouse oocytes in vivo and in vitro. Feral. Steril. (2000) 73:620–626.
   PubMed Web of Science ®Google Scholar
• HAMMOND M, HALME J, TALBERT L: Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet. Cynecol. (1983) 62:196–202.
   Web of Science ®Google Scholar
• CARPENTER SE: Implantation. In: Reproductive Medicine and Surgery EE Wallach, HA Zacur (Eds), Mosby, St. Louis, MO, USA (1995):158–165.
   Google Scholar
• FRITZ MA, HOLMES RT, KEENAN EJ: Effect of clomiphene citrate treatment on endometrial estrogen and progesterone receptor induction in women. Am. I. Obstet. Cynecol (1991) 165:177–185.
   PubMed Web of Science ®Google Scholar
• THATCHER SS, DONACHIE KM, GLASIER A, HILLIER SG, BAIRD DT: The effects of clomiphene citrate on the histology of human endometrium in regularly cycling women undergoing in vitro fertilization. Feral. Steril (1988) 49:296–301.
   PubMed Web of Science ®Google Scholar
• YEKO TR, NICOSIA SM, MAROULIS GB, BARDAWIL WA, DAWOOD MY: Histology of midluteal corpus luteum and endometrium from clomiphene citrate-induced cycles. Fertil. Steril (1992) 57:28–32.
   PubMed Web of Science ®Google Scholar
• SEREEPAPONG W, TRIRATANACHAT S, SAMPATANUKUL P, PRUKSANANONDA K, BOONKASEMSANTI K, REINPRAYOON D: Effects of clomiphene citrate on the endometrium of regularly cycling women. Feral. Steril (2000) 73:287–291.
   PubMed Web of Science ®Google Scholar
• YAGEL S, BEN-CHETRIT A, ANTEBY E, ZACUT D, HOCHNER-CELNIKIER D, RON M: The effect of ethinyl estradiol on endometrial thickness and uterine volume during ovulation induction by clomiphene citrate. Fertil. Steril. (1992) 57:33–36.
   PubMed Web of Science ®Google Scholar
• SHIMOYA K, TOMIYAMA K, HASHIMOTO K et al.: Endometrial development was improved by transdermal estradiol in patients treated with clomiphene citrate. Cynecol. Obstet. Invest. (1999) 47(4):251–254.
   PubMed Web of Science ®Google Scholar
• GERLI S, GHOLAMI H, MANNA A, DI FREGA D, VITIELLO C, UNFER V: Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: a comparative, randomized study. Feral. Steril (2000) 73(1):85–89.
   PubMed Web of Science ®Google Scholar
• BEN-AMI M, GESLEVICH Y, MATILSKY M et al.: Exogenous estrogen therapy concurrent with clomiphene citrate-lack of effect on serum sex hormone levels and endometrial thickness. Cynecol. Obstet. Invest. (1994) 37(3):180–182.
   PubMed Web of Science ®Google Scholar
• BATEMAN BG, NUNLEY WC Jr, KOLP LA: Exogenous estrogen therapy for treatment of clomiphene citrate-induced cervical mucus abnormalities: is it effective? Feral. Steril. (1990) 54:577–579.
   PubMed Web of Science ®Google Scholar
• WU CH, WINKEL CA: The effect of therapy initiation day on clomiphene citrate therapy. Feral. Steril (1989) 52:564–568.
   PubMed Web of Science ®Google Scholar
• SALEH A, BILJAN MM, TAN SSSL, TULANDI T: Effects of tamoxifen (Tx) on endometrial thickness and pregnancy rates in women undergoing superovulation with clomiphene citrate (CC) and intrauterine insemination (IUI). Feral. Steril. (2000) 74(S1):S90.
   Google Scholar
• BOOSTANFAR R, JAIN JK, PAULSON RJ, MISHELL DR Jr: A prospective randomized trial comparing clomiphene citrate with tamoxifen for ovulation induction in anovulatory women. Feral. Steril (2000) 74\(Suppl. 1):562.
   Google Scholar
• HURST BS, TJADEN BL, KIMBALL A, SCHLAFF WD, DAMEWOOD MD, ROCK JA: Superovulation with or without intrauterine insemination for the treatment of infertility. J. Reprod. Med. (1992) 37(3):237–239.
   PubMed Web of Science ®Google Scholar
• MITWALLY MFM, CASPER RF: The aromatase inhibitor, letrozole, decreases FSH dose required for ovarian superovulation. Proc. Ann. Meet. Can. Fertilio Androl Soc. (2000).
   Google Scholar
• MITWALLY MFM, CASPER RF: Aromatase inhibition decreases FSH dose needed during controlled ovarian hyperstimulation: A controlled prospective ./. Soc. Cynecol. Invest. (2001) 8:85A.
   Google Scholar
• MITWALLY MFM, CASPER RF: Aromatase inhibition improves response to controlled ovarian hyperstimulation without the antiestrogenic effects of clomiphene citrate. Program Abstr. Ann. Meet. Eur. Soc. Hum. Reprod. Embryo]. (2001) 16:71 (Abstract).
   Google Scholar
• MITWALLY MFM, CASPER RF: Aromatase inhibition improves ovarian response to FSH: a potential option for low responders during ovarian stimulation. Feral. Steril (2001) 75(4, Suppl. 1):58–59.
   Google Scholar
• MITWALLY MFM, CASPER RF: Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Feral. Steril. (2002) 77(4):776–780. This study included a series of patients who had poor response to gonadotrophins in at least two treatment cycles. The authors reported that aromatase inhibition improved the ovarian response to gonadotrophin stimulation with achievement of optimum ovarian stimulation despite the administration of a significantly lower gonadotrophin dose. Moreover, pregnancy was achieved in three of the eight letrozole treatment cycles.
   Google Scholar
• MITWALLY MFM, CASPER RF: Single dose administration of the aromatase inhibitor, letrozole: a simple and convenient effective method of ovulation induction. Feral. Steril (2001) 76\(Suppl. 1):S94–S95.
   Google Scholar
• SAMMOUR A, BILJAN MM, TAN SL, TULANDI T: Prospective randomized trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination (IUI). Feral. Steril (2001) 76\(Suppl. 1):S110.
   Google Scholar
• ••In this well-designed, randomised,prospective study, the authors reported a superior uterine environment in patients treated with an aromatase inhibitor compared with CC treatment, reflecting the lack of the antioestrogenic effects with aromatase inhibitor treatment. Although a nonsignificant increase in pregnancy rate was observed in patients who received aromatase inhibitor treatment (16.7 versus 5.6% per patient, p = 0.55), this almost threefold increase in pregnancy rate could have been significant if a larger group of patients was included.
   Google Scholar
• BILJAN MM, TAN SL, TULANDI T: Prospective randomized trial comparing the effects of 2.5 and 5.0 mg of letrozole (LE) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation. Feral Steril. (2002) 78\(Suppl. 1):S55.
   Google Scholar
• EL HELW B, EL SADEK M, MATAR H, FOUAD S, EL NOMROSY K, ABBASH: Single dose Letrozole versus Clomiphene citrate for superovulation prior to intrauterine insemination: a prospective randomised study. Program Abstr: Ann. Meet. Eur. Soc. Hum. Reprod. Embryo]. (2002) 17:75 (Abstract 0–209).
   Google Scholar
• HEALEY S, SYLVESTRE C, TAN SL, TULANDI T, BILJAN M: A comparison between superovulation with FSH and a combination of FSH and letrozole. Feral. Steil] (2002) 78\(Suppl. 1):S55–S56.
   Google Scholar
• PRAPAS G, PISTOFIDIS M, TIKA M, PELEKANOS: Experience with the use of an aromatase inhibitor (letrozole)in patients with a history of poor ovarian responce in previous assisted reproduction cycles. Program Abstr. Ann. Meet. Eur. Soc. Hum. Reprod. Embryo]. (2002) 17:75 (Abstract 0–098).
   Google Scholar
• SCHOOLCRAFT W, SURREY E, MINJAREZ D, GARDNER DK: Antagonistiletrozole protocol for patients failing microdose agonist flare stimulation. Feral. Steril. (2002) 78\(Suppl. 1):5234.
   Google Scholar
• AL-OMARI WR, AL-HADITHI N, SULAIMAN WR, IZAT B: Comparison of two aromatase inhibitors in clomiphene resistant PCOS. Program Abstr. Ann. Meet. Eur. Soc. Hum. Reprod. Embryo]. (2002) 17:75 (Abstract 0–243).
   Google Scholar
• KRASNOPOLSKAYA K KALUINA A: Application of aromatase inhibitors (Anastrosol) in IVF program for the treatment of infertility associated with severe endometriosis. Program Abstr: Ann. Meet. Eur. Soc. Hum. Reprod. Embryo]. (2002) 17:75 (Abstract P–438).
   Google Scholar
• BULUN SE, ZEITOUN KM, TAKAYAMA K AND SASANO H: Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. Mol. Endocrinol (2000) 1:35–42.
   Google Scholar
• VIGNALI M, INFANTINO M, MATRONE R et al.: Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Feral. Steril. (2002) 78(4):665–678.
   PubMed Web of Science ®Google Scholar
• FANG Z, YANG S, GURATES B et al: Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. I Clin. Endocrinol Metab. (2002) 87(7):3460–3466.
   PubMed Web of Science ®Google Scholar
• SANTEN RJ: To block estrogen's synthesis or action: that is the question. J. Clin. Endocrinol Metab. (2002) 87(7):3007–3012.
   PubMed Web of Science ®Google Scholar
• BULUN SE, GURATES B, FANG ZJ et al.: Mechanisms of excessive estrogen formation in endometriosis. Reprod. Immunol (2002) 55(1-2):21–33.
   PubMed Web of Science ®Google Scholar
• MEINHARDT U, MULLIS PE: The aromatase cytochrome P450 and its clinical impact. Horm. Res. (2002) 57(5-6):145–152.
   PubMed Web of Science ®Google Scholar
• YANG S, FANG Z, SUZUKI TJ et al: Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (Cl EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase. Chi]. Endocrinol Metab. (2002) 87(5):2336–2345.
   PubMed Web of Science ®Google Scholar
• SCHLEGEL PN: How to do a work-up for male infertility. Med. Asp. Hum. Sex. (1991) 25:28.
   Google Scholar
• PAVLOVICH CP, KING P, GOLDSTEIN M et al.: Evidence of a treatable endocrinopathy in infertile men. I Dia. (2001) 165:837.
   Google Scholar
• JONES TM, FANG VS, LAUNDAU RL et al.: Direct inhibition of Leydig cell function by estradiol. I Clin. Endocrinol Metab. (1978) 47:1369.
   Google Scholar
• KALLA NR, NISULA BC, MENARD R et al.: The effect of estradiol on testicular testosterone biosynthesis. Endocrinology (1980) 106:35.
   PubMed Web of Science ®Google Scholar
• AKIYAMA H: A study on testicular aromatase activity-spermatogenic damage in high testicular E2 models of rat. Nippon Hinyokika Gakkai. Zasshi. (1997) 88:649.
   PubMedGoogle Scholar
• BRODIE AM: Aromatase inhibition and its pharmacologic implications. Biochem. Pharmacol (1985) 34:3213.
   PubMed Web of Science ®Google Scholar
• VIGERSKY RA, GLASS AR: Effects of [DELTA]l-testolactone on the pituitary-testicular axis in oligospermic men. J. Endocrinol Metab. (1981) 52:897.
   PubMed Web of Science ®Google Scholar
• CLARK RV, SHERINS RJ: Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with cross-over. I Andra (1989) 10:240.
   Google Scholar
• RAMAN JD, SCHLEGEL PN: Aromatase inhibitors for male infertility. J. Dia. (2002) 167(2, Pt 1):624–629.
   Google Scholar
• TERRIS MK, MCCALLUM SW: Re: Aromatase inhibitors for male infertility. J. Dia. (2002) 168(4, Pt 1):1509 (Letter).
   Google Scholar
• HAIDL G: Management strategies for male factor infertility. Drugs (2002) 62(12):1741–1753.
   PubMed Web of Science ®Google Scholar
• PALTER SF, TAVARES AB, HOURVITZ A, VELDHUIS JD, ADASHI EY: Are estrogens of import to primate/human ovarian folliculogenesis? Endocr. Rev (2001) 22 (3):389–424.
   Google Scholar
• YANASE T, SIMPSON ER, WATERMAN M: 17-Hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr. Rev (1991) 12:91–108.
   PubMed Web of Science ®Google Scholar
• MALLIN SR: Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency: two sisters with amenorrhea, hypokalemia, hypertension and cystic ovaries. Ann. Intern. Med. (1968) 70:69–73.
   Web of Science ®Google Scholar
• ARAKI S, CHIKAZAWA K, SEKIGUCHI I, YAMAUCHI H, MOTOYAMA M, TAMADA T: Arrest of follicular development in a patient with 17-hydroxylase deficiency: folliculogenesis in association with a lack of estrogen synthesis in the ovaries. Feral. Steril. (1987) 47:169–172.
   PubMed Web of Science ®Google Scholar
• NAGAMANI M, DINH TV: 17-Hydroxylase deficiency in genetic females. A report of two cases.' Reprod. Med. (1986) 31:734–738.
   PubMed Web of Science ®Google Scholar
• ROGER M, MERCERON RE, GIRARD F et al.: Dexamethasone-suppressible hypercorticosteronism in 46XX subjects with ambiguous genitalia and ovarian cysts. Partial defect of 17-hydroxyase or 17,20-desmolase. Horm. Res. (1982) 16:23.
   Google Scholar
• RABINOVICI J, BLANKSTEIN J, GOLDMAN B et al: IVF and primary embryonic cleavage are possible in 17-hydroxylase deficiency despite extremely low intrafollicular 1713 E2. I Clin. Encrinol Metab. (1989) 68:693–697.
   PubMed Web of Science ®Google Scholar
• GEIER A, LUNENFELD B, PARIENTE C et al: Estrogen receptor binding material in blood of patients following clomiphene citrate administration: determination by radioreceptor assay. Feral. Steil]. (1987) 47:778–784.
   PubMed Web of Science ®Google Scholar
• PARIENTE C, RABINOVICI J, LUNENFELD B et al: Steroid secretion by granulosa cells isolated from a woman with 17-hydroxylase deficiency. J. Glib. Endocrinol. Metab. (1990) 71:984–987.
   PubMed Web of Science ®Google Scholar
• ZELINSKI-WOOTEN MB, HESS DL, WOLF DP, STOUFFER RL: Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys. Feral. Steril. (1994) 61:1147–1155.
   PubMed Web of Science ®Google Scholar
• MANNAERTS B, UILENBROEK J, SCHOT P, DELEEUW R: Folliculogenesis in hypophysectomized rats after treatment with recombinant human follicle-stimulating hormone. Biol. Reprod. (1994) 51:72–81.
   PubMed Web of Science ®Google Scholar
• ITO Y, FISHER CR, CONTE FA, GRAMBACH MM, SIMPSON ER: Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc. Natl. Acad. Sci. USA (1993) 90:11673–11677.
   PubMed Web of Science ®Google Scholar
• CONTE FA, GRUMBACH MM, ITO Y, FISHER CR, SIMPSON ER: A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). j Clin. Endocrinol. Metab. (1994) 78:1287–1292.
   PubMed Web of Science ®Google Scholar
• MORISHIMA A, GRUMBACH MM, SIMPSON ER, FISHER C, QUIN K: Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Gbh Endocrinol. Metab. (1995) 80:3689–3698.
   PubMed Web of Science ®Google Scholar
• MULLIS PE, YOSHIMURA N, KUHLMANN B, LIPPUNER K, JAEGER P, HARADA H: Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J. Clin. Endocrinol. Metab. (1997) 82:1739–1745.
   PubMed Web of Science ®Google Scholar
• BULUN SE: Aromatase deficiency in women and men: would you have predicted the phenotypes? I Glib. Endocrinol. Metab. (1996) 81:867–871.
   Web of Science ®Google Scholar
• COUZINET B, LESTRAT N, BRAILLY S, FOREST M, SCHAISON G: Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. Clirr. Endocrinol. Metab. (1988) 66:552–556.
   PubMed Web of Science ®Google Scholar
• SCHOOT DCJM, HERJAN JT, BENNINK C et al.: Human recombinant FSH induced growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated GT deficiency. I Glib. Endocrinol. Metab. (1992) 74:1471–1473.
   PubMed Web of Science ®Google Scholar
• MANNAERTS B, LEEUW R, VANRAVESTEIN JG, WEZENBEEK P, SCHUURS A, KLOOSTERBOER H: Comparative in vitro and in vivo studies on the biological characteristics of human recombinant follicle-stimulating hormone. Endocrinology (1991) 129:2623–2630.
   PubMed Web of Science ®Google Scholar
• SHOHAM Z, MANNAERTS B, INSLER V, COELINGH HB: Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil. Steril. (1993) 59:738–742.
   PubMed Web of Science ®Google Scholar
• SHOHAM Z, BALEN A, PATEL A, JACOBS HS: Results of ovulation induction using human menopausal gonadotropins or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Feral. Steril. (1991) 56:1048–1053.
   PubMed Web of Science ®Google Scholar
• ZELINSKI-WOOTEN MB, HESS DL, BAUGHMAN WO, MOLSKNESS TA, WOLF DP, STOUFFER RL: Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in Rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function. Clip. Endocrinol. Metab. (1993) 76:988–995.
   PubMed Web of Science ®Google Scholar
• SELVARAJ N, SHETTY G, VIJAYALAKSHMI K, BHATNAGAR AS, MOUD GAL NR: Effect of blocking oegrogen synthesis with a new generation aromatase inhibitor CGS 16949A on follicular maturation induced by pregnant mare serum gonadotrophin in the immature rat. J. Endocrinol. (1994) 142:563–570.
   PubMed Web of Science ®Google Scholar
• SELVARAJ J, BHATNAGAR AS, MOUD GAL NR: Aromatase inhibition during follicular phase in Bonnet monkeys: is there a role for estrogen in follicular maturation in the primate? Endocrine (1995) 3:245–249.
   PubMed Web of Science ®Google Scholar
• SHETTY G, KRISHNAMURTHY H, KRISHNAMURTHY HN, BHATNAGAR AS, MOUDGAL RN: Effect of estrogen deprivation on the reproductive physiology of male and female primates. I Steroid Biochern. Mol. Biol. (1997) 61:157–166.
   PubMed Web of Science ®Google Scholar
• PAESI FJA: The effect of small doses of oestrogen on the ovary of the immature rat. Acta Endocrinol. (1952) 11:251–268.
   PubMedGoogle Scholar
• ZELINSKI-WOOTEN MB, HESS DL, WOLF DP, STOUFFER RL: Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys. Feral. Steril. (1994) 61:1147–1155.
   PubMed Web of Science ®Google Scholar
• WANG XN, GREENWALD GS: Human chorionic gonadotropin or human recombinant follicle-stimulating hormone (FSH)-induced ovulation and subsequent fertilization and early embryo development in hypophysectomized FSH-primed mice. Endocrinology (1993) 132:2009–2016.
   PubMed Web of Science ®Google Scholar
• MITWALLY MFM, CASPER RF: Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Feral. Steril. (2002) 78\(Suppl. 1):S277–S278.
   Google Scholar
• Package insert of letrozole (Femara).
   Google Scholar
• Package insert of anastrozole (Arimidex9.
   Google Scholar